Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $25000.0.

  • Sight Sciences' Cash from Financing Activities fell 6710.53% to $25000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 1217142.86%. This contributed to the annual value of $5.0 million for FY2024, which is 34963.77% up from last year.
  • Sight Sciences' Cash from Financing Activities amounted to $25000.0 in Q3 2025, which was down 6710.53% from $485000.0 recorded in Q2 2025.
  • Over the past 5 years, Sight Sciences' Cash from Financing Activities peaked at $252.7 million during Q3 2021, and registered a low of -$942000.0 during Q1 2024.
  • Over the past 5 years, Sight Sciences' median Cash from Financing Activities value was $118000.0 (recorded in 2023), while the average stood at $13.7 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 14874823.53% in 2021, then plummeted by 50384.62% in 2024.
  • Sight Sciences' Cash from Financing Activities (Quarter) stood at $91000.0 in 2021, then surged by 792.31% to $812000.0 in 2022, then crashed by 53.69% to $376000.0 in 2023, then skyrocketed by 1333.24% to $5.4 million in 2024, then plummeted by 99.54% to $25000.0 in 2025.
  • Its last three reported values are $25000.0 in Q3 2025, $485000.0 for Q2 2025, and $16000.0 during Q1 2025.